What if the latest advancements and widest scope of effective infertility treatment options were all within reach and in one place? Well, they are at RMANJ.
Across all our offices, including our new state-of-the-art facility in Basking Ridge, NJ, we offer 360° of fertility care in a comfortable, reassuring setting. Our physicians, nurses, financial counselors, and other team members surround you with the widest scope of treatment options and choices in care.
Some of our team here at RMANJ were patients just like you, so we understand fertility treatment is often life-changing and emotional. We also understand that there are other things that are important during your cycle –family, friends, and work.
Our doctors – not technicians – conduct cycle monitoring 7 days a week, providing a higher level of personalized care and a chance to have those everyday questions answered every day. Our entire team takes pride in offering the simple touches and conveniences that help you stay positive.
In-Vitro Fertilization (IVF) is the most effective and most common fertility treatment today. The process starts in a laboratory with the fertilization of the egg, which forms an embryo. The embryo is then implanted in the uterus of the female carrier. RMANJ has greatly improved the effectiveness of this procedure by developing technology that screens selected embryos in just four hours. This test identifies those with a normal number of chromosomes to implant in the uterus - scientifically supporting greater chances for a healthy pregnancy.
Many IVF programs are still relying heavily on judging an embryo’s potential to implant by how it looks under the microscope, essentially judging a book by its cover. However, RMANJ led the development of a one-of-a-kind, well validated, 24-chromosome screening process called SelectCCS which identifies whether embryos have a normal number of chromosomes or have an abnormal number of chromosomes. Published data suggests that 50-70% of miscarriages are due to embryos with too few or too many chromosomes.
In 2013 RMANJ donated SelectCCS to the Foundation for the Assessment and Enhancement of Embryonic Competence (FAEEC), a non-profit organization dedicated to improving outcomes and advancing knowledge in the areas of research, diagnosis, and education. (www.faeec.org)